Caripazim, lyophilizate 350 pe 10 ml

Caripazim promotes the breakdown of necrotic tissues, softening of viscous secretions, blood clots.

In addition, when using the drug for the treatment of musculoskeletal disorders with electrophoresis the elasticity of ligaments and cartilage tissue increases, a resorption effect occurs aimed at spinal hernias and so on.

When used externally the active components are not absorbed and do not have a systemic effect on the body.

All the enzymes that are included in this remedy are broken down and biotransformed in the liver.

Indications

Third degree burns, to speed up the rejection of scabs and the release of wounds from suppuration and necrotic tissue.

In addition, for some time now the drug has been actively used for the treatment of orthopedic, traumatological, neurosurgical and neurological lesions using electrophoresis, for example:

spinal osteochondrosis;
discogenic radiculitis;
intervertebral disc herniation

Pharmacological effect

Karipazim promotes the breakdown of necrotic tissue, softening viscous secretions and blood clots.

In addition, when using the drug for the treatment of disorders of the musculoskeletal system using electrophoresis, the elasticity of ligaments and cartilage tissue increases, a resolving effect occurs aimed at vertebral hernias, and so on.

When used externally, the active components are not absorbed and do not exhibit a systemic effect on the body.

All enzymes that are part of this product are destroyed and biotransformed in the liver.

Special instructions

The drug Karipazim does not have a negative effect on the ability to drive a car or operate machinery.

Active ingredient

Papaya milky Ssk

Composition

Active components:

papain,

chymopapain A,

chymopapain B,

peptidase A,

peptidase B

lysocine

Contraindications

This product should not be used for any type of injection, or for:

exacerbation of inflammatory processes;
sequestration of disc herniation;
drug intolerance;
lactation;
pregnancy.

Side Effects

Allergic reactions.

Interaction

No clinically significant interactions of caripazim with other drugs have been established.

Overdose

Cases of overdose have not been described.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 4 °C.

Shelf life

1.5 years

Manufacturer

Wifitech CJSC, Russia